A mammogram does more than search for suspicious lumps. It can also show whether a woman’s breasts contain a large amount of dense tissue, a feature that has long been associated with a higher chance of developing breast cancer. For many years, breast density was especially important because it could hide small tumors on mammograms. […]
The post Dense Breasts May Create a Hidden Cancer-Friendly Environment appeared first on Knowridge Science Report.
Australian researchers have identified a promising new approach that could help stop one of the most aggressive forms of breast cancer from spreading. Triple-negative breast cancer becomes especially dangerous once tumor cells escape the breast and establish themselves elsewhere in the body. Australian researchers have now identified a molecular weakness that could eventually help determine [...]Triple-negative breast tumors may hijack immune cells to attract nerves that help the cancer grow. Nerves growing through a tumor may help an aggressive breast cancer survive, expand, and resist treatment. University of Oklahoma researchers have identified how triple-negative breast cancer may recruit those nerves by turning the body’s own immune cells into messengers. Networks [...]Chromosome instability and aneuploidy have long posed a conundrum in cancer biology, profoundly shaping tumor genomes yet remaining challenging to decode functionally. In a groundbreaking study published in Nature, Al-Zahrani et al. unveil a novel approach, CRISPR-KOALA, that systematically links large-scale chromosomal alterations to specific cancer-driving genes in basal-like breast cancer (BLBC).
BLBC, a highly aggressive subtype characterized by extensive copy-number alterations (CNAs), often harbors arm-level chromosomal imbalances whose contribution to tumorigenesis remains elusive. The researchers developed CRISPR-KOALA to conduct high-throughput bidirectional genetic screens directly in immunocompetent mouse models, overcoming previous barriers related to the complexity and scale of genes affected by aneuploidy.
By focusing on the ten most frequent human chromosome-arm alterations seen in BLBC, the team screened over 3,700 mouse orthologues of genes located on these arms. The screen identified 90 putative cancer driver genes—a majority of which had not been previously linked to cancer—revealing a diverse functional landscape shaping tumor biology. Among the implicated pathways were key signaling networks such as MAPK, HIPPO, and WNT, highlighting the heterogeneity intrinsic to BLBC progression.
Strikingly, manipulating these driver genes in Trp53-mutant mouse models was sufficient to bypass the need for whole-arm CNAs, suggesting that tumors exploit specific genes within broad chromosomal alterations to fuel oncogenesis. This finding challenges the traditional view that arm-level aneuploidies function merely as genomic chaos, instead presenting them as evolutionary selections for particular drivers.
One gene, PLGRKT, localized on chromosome 9p, emerged as a potent oncogene. The team showed that PLGRKT promotes tumor growth by enhancing mitochondrial robustness and boosting reactive oxygen species detoxification. This mechanistic insight connects chromosomal instability not only to genetic selection but also to metabolic adaptations that support cancer cell survival under stress.
Overall, this study delivers a transformative platform and a compendium of cancer drivers that illuminate how aneuploidy sculpts tumor heterogeneity. By delineating driver genes nested within widespread CNAs, it provides an invaluable resource for targeting breast cancer’s genetic complexity with greater precision.
The implications extend beyond breast cancer, offering a blueprint for dissecting arm-level aneuploidy in diverse malignancies. As cancer therapies increasingly focus on genetic vulnerabilities, CRISPR-KOALA represents a leap toward untangling the intricate link between chromosome-level alterations and oncogenic processes.
This work underscores the power of integrating genomic data with functional genetics in vivo, setting the stage for novel drug targets and therapeutic strategies aimed at the underexplored realm of aneuploidy-driven tumorigenesis.
Subject of Research: Chromosome instability and cancer driver genes in basal-like breast cancer
Article Title: Aneuploidy selects for the acquisition of driver genes in breast cancer
Article References:
Al-Zahrani, K.N., Langille, E.R., Nurtanto, J. et al. Aneuploidy selects for the acquisition of driver genes in breast cancer. Nature (2026). https://doi.org/10.1038/s41586-026-10752-9
Image Credits: AI Generated
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight. A large new study found that women taking these [...]
The breast cancer 'breakthrough' is a story of overtreatment, not a triumph of testing, says Dr Clare Craig. The truth is, the genetic test failed, but it's being rolled out anyway.
The post The Breast Cancer ‘Breakthrough’ is a Story of Overtreatment Not a Triumph of Testing appeared first on The Daily Sceptic.
Medications such as Ozempic, Wegovy, Mounjaro, and Zepbound have become household names in recent years. Originally developed to help people with type 2 diabetes control their blood sugar levels, these drugs later gained enormous attention because of their ability to help people lose significant amounts of weight. Millions of people now use them, and doctors […]
The post Could Popular Weight Loss Drugs Prevent Breast Cancer? appeared first on Knowridge Science Report.
A gene normally responsible for repairing DNA may have a darker side when produced in excess. Cancer treatment is increasingly moving beyond where a tumor forms and focusing instead on the genetic flaws that drive it. Now, researchers at Penn State College of Medicine have identified an unexpected DNA repair gene that could help expand [...]New findings suggest cell size could sharpen cancer prognosis.
Login